EUVIMED · CrossrefZeitschrift
Journal of Pancreatology
ISSN 2096-5664 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Acute pancreatitis: A two-year update on epidemiology, clinical diagnosis, treatment, and outcomes
Consensus on germline variant testing and clinical application in patients with pancreatitis in China (2026)
The lost time before EUS: A national benchmark of imaging-to-EUS timing and downstream treatment intervals in pancreatic cancer
Asian Pancreas Consortium: Building evidence through collaborative research for pancreatic care across Asia
Tumor-associated macrophages positive for SPP1 indicate a poorer clinical prognosis in pancreatic ductal adenocarcinoma
Two-drain versus three-train strategy in robotic-assisted pancreaticoduodenectomy: impact on complications
Epidemiological trends and predictions of pancreatitis in China from 1990 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021
Biochemical pharmacology of diabetes and its complications: frontiers in therapy
Non-alcoholic fatty pancreas disease: an updated review
Comparison of outcomes with stapler versus hand-sewn closure of the pancreatic stump following minimally invasive distal pancreatectomy: a retrospective cohort study
Platinum-based chemotherapy for metastatic insulinoma harboring germline mutation in DNA damage repair pathway: a case report
Acute pancreatitis: pathogenesis and emerging therapies
Artificial intelligence in pancreatic surgery: current applications
The effect of using long-acting octreotide as adjuvant therapy for patients with grade 2 pancreatic neuroendocrine tumors after radical resection
An overview of pancreatic trauma
Training and learning curves in minimally invasive pancreatic surgery: from simulation to mastery
Mechanisms of Hippo pathway in the pancreatic cancer
Can pathologists reliably establish ampulla of Vater carcinoma histologic subtype on H&E alone? Concordance of subtype and comparison to immunohistochemistry-established subtype
Conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma: where do we stand in 2018?
The dual role of HMGB1 in pancreatic cancer
Pancreatic cystic tumors: an update
A Chinese consensus statement on the diagnosis and treatment of pancreatic exocrine insufficiency after pancreatic surgery (2018)
Gastroenteropancreatic neuroendocrine tumor registry study in China
Overexpression of catechol-O-methyltransferase occurs early in the progression of pancreatic cancer
The Journal of Pancreatology
Advances of pathological complete response after neoadjuvant therapy for pancreatic cancer
PD-1 immunotherapy in pancreatic cancer: current status
Prognostic factors for disease-free survival in patients with pancreatic ductal adenocarcinoma after surgery: a single center experience
The current surgical treatment of pancreatic cancer in China: a national wide cross-sectional study
Pancreatic cancer surgery with vascular resection: current concepts and perspectives
EUVIMED